S
Stockadora
Back to Insider Trading View Full Company Profile

BIOA

UNKNOWN

BioAge Labs, Inc.

CIK: 0001709941

Strong Sell (90% confidence)

Last activity: 3 days ago

Financial Metrics

As of Dec 31, 2025 (10-K)

Total Cash $188.89M

Insider Roster (3 total, 3 active)

Insider Buys Sells Net Value Holdings
Fortney Kristen
Chief Executive Officer
 		0 1 -$4.22M
976,949 shares
$17.70M
RUBIN PAUL D
Chief Medical Officer
 		0 6 -$1.46M
Holdings: -
Value: -
GOLDSTEIN DOV A MD
Chief Financial Officer
 		0 4 -$532K
24,331 shares
$500K

Recent Transactions

SELL RUBIN PAUL D (Chief Medical Officer)

8,820 shares @ $17.81

$157K

Apr 1, 2026

Conviction: | View SEC Filing →
SELL RUBIN PAUL D (Chief Medical Officer)

7,433 shares @ $20.30

$151K

Mar 2, 2026

Conviction: | View SEC Filing →
SELL RUBIN PAUL D (Chief Medical Officer)

7,433 shares @ $18.75

$139K

Feb 2, 2026

Conviction: | View SEC Filing →
SELL Fortney Kristen (Chief Executive Officer)

233,107 shares @ $18.12

$4.22M

Jan 13, 2026

Conviction: | View SEC Filing →
SELL GOLDSTEIN DOV A MD (Chief Financial Officer)

11,663 shares @ $20.54

$240K

Jan 13, 2026

Conviction: | View SEC Filing →
SELL GOLDSTEIN DOV A MD (Chief Financial Officer)

8,974 shares @ $18.43

$165K

Jan 13, 2026

Conviction: | View SEC Filing →
SELL GOLDSTEIN DOV A MD (Chief Financial Officer)

4,440 shares @ $19.45

$86K

Jan 13, 2026

Conviction: | View SEC Filing →
SELL GOLDSTEIN DOV A MD (Chief Financial Officer)

1,923 shares @ $21.08

$41K

Jan 13, 2026

Conviction: | View SEC Filing →
SELL RUBIN PAUL D (Chief Medical Officer)

7,433 shares @ $12.85

$95K

Jan 2, 2026

Conviction: | View SEC Filing →
SELL RUBIN PAUL D (Chief Medical Officer)

18,000 shares @ $12.00

$216K

Dec 9, 2025

Conviction: | View SEC Filing →
SELL RUBIN PAUL D (Chief Medical Officer)

68,897 shares @ $10.19

$702K

Dec 4, 2025

Conviction: | View SEC Filing →

⚠️ Important Disclaimer

• This is AI-generated analysis for educational purposes only, not financial advice.

• Insider trading data is derived from SEC Form 4 filings and may contain errors.

• Always conduct your own research and consult qualified financial advisors before making investment decisions.